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Psoriasis is a common chronic skin disease with strong genetic associations and
environmental triggers. Patients with psoriasis develop sore throats much more
frequently than nonpsoriatic individuals and it is well documented that strepto-
coccal throat infections can trigger the onset of psoriasis, and such infections
cause exacerbation of chronic psoriasis. It is now generally accepted that psoriatic
lesions are caused by abnormal reactivity of specific T lymphocytes in the skin.
However, it has been shown in recent years that activation of specific immunity
is always preceded by activation of nonspecific innate immune mechanisms, and
that abnormalities in the innate immune system can cause dysregulation in spe-
cific immune responses. Here we explore the possible immune mechanisms that
are involved in the link between infection of the tonsils and this inflammatory
skin disease. Moreover, we survey the literature and discuss the suitability of
tonsillectomy as a treatment for psoriasis.
Psoriasis, a T-cell-mediated autoimmune
disease
Psoriasis is a common chronic inflammatory skin disease, most
often characterized by thickened erythematous scaly plaques,
and appears in a variety of forms with distinct characteristics.
The most common form, psoriasis vulgaris, affects 1–3% of
the Caucasian population,1 usually persists – with 40% devel-
oping seronegative arthritis – and has a very negative impact
on quality of life.2 Psoriasis is generally regarded as a T-cell-
mediated autoimmune disease,3–5 with treatments targeting T
cells being very effective;6,7 indeed, blocking of T-cell entry
into the epidermis prevents development of hyperplasia in a
mouse model of psoriasis.8 There is considerable literature in
support of psoriasis being driven by T cells recognizing pep-
tide antigens (reviewed in Valdimarsson et al.9). T cells from
patients with psoriasis show increased responses to homolo-
gous peptides from streptococcal M proteins10,11 and human
epidermal keratins;10,12,13 thus, it is possible that psoriasis
may occur as a consequence of T cells cross-reacting with epi-
topes from streptococcal M proteins and human keratins.3,5
The palatine tonsils might play a major role in psoriasis as
they are a common site for streptococcal infections and, as
immune sentries loaded with antigen-presenting cells and T
cells, are likely a major site for T-cell priming against such
antigens. Here we detail how the immune function of the ton-
sils could lead to the initiation and exacerbation of psoriasis
and we survey potential interventions.
The tonsils, immunological sentries of the
pharynx
The mucosal surfaces of the mouth, throat and upper respira-
tory tract are the first major barrier protecting the host from
potentially invading microorganisms, and integral to this
defence are the tonsils, which provide a protective immunolog-
ical ring (Waldeyer’s ring) at the openings of both the digestive
and respiratory tracts.14 The palatine tonsils have a surface lined
by a stratified squamous epithelium that extends into deep and
branched crypts, increasing their total surface area. The surface
of the crypts is lined with a reticulated epithelium, which
in parts may be only one cell thick. The reticulated tonsil
epithelium has a unique cellular composition where epithelial
cells, stromal cells, intraepithelial lymphocytes, dendritic cells
(DCs), neutrophils and macrophages are all situated in close
proximity, which is ideal for productive antigen sampling. In
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the subepithelial space are B-cell-rich lymphoid follicles that
foster the development of memory B cells and antibody pro-
ducing plasma cells, a process that requires the interaction of a
number of B-cell, T-cell and DC subsets.15 Six phenotypes of
DC have been identified in the tonsils,16,17 each with a different
location and function. DCs are particularly adept at antigen
sampling and processing and presentation of peptide antigens,
and influence the T helper 1 (Th1) ⁄Th2 ⁄Th17 balance of
T-cell-mediated responses.18
The involvement of streptococci in psoriasis
The most frequent tonsil diseases are recurrent infections and
abnormal enlargement of the tonsils (hypertrophy), which
may result in the need for tonsillectomy. Streptococcus pyogenes in-
fections are associated with acute and recurrent throat infec-
tions,19,20 while Haemophilus influenzae infections are thought to
stimulate hypertrophic responses.21 Throat infection with
b-haemolytic streptococci is the only well-defined external
trigger that has been convincingly associated with initiation
and acute exacerbation of psoriasis.22–26 This association was
corroborated in a prospective study that concluded that
patients with psoriasis reported a sore throat 10 times more
often than household controls, and that streptococcal throat
infections can cause exacerbation of chronic plaque psoriasis.24
Furthermore, a-streptococci are likely to have a role in pustu-
losis palmaris et plantaris (PPP), a chronic, recurrent, inflam-
matory skin disease restricted to the palms and soles.27 These
two inflammatory skin diseases appear to benefit from tonsil-
lectomy,28–30 suggesting the importance of the palatine tonsils
in inflammatory diseases outside the throat. Tonsils from indi-
viduals with PPP differ from recurrently infected tonsils with
regard to histology and the expression of skin homing mole-
cules by T cells. Furthermore, the size of the T-cell area in
tonsils has been associated with skin improvement after tonsil-
lectomy.30 In this respect, we have recently demonstrated that,
compared with nonpsoriatic individuals, tonsils from patients
with psoriasis contain an increased frequency of T cells with
skin homing potential (Sigurdardottir, manuscript in prepara-
tion). Moreover, superantigens from b-haemolytic streptococci
have been demonstrated to enhance T-cell expression of cuta-
neous lymphocyte-associated antigen (CLA),31,32 a carbo-
hydrate moiety expressed on 80% of T cells in the skin,33 and
the frequency of CLA+CD8+ T cells in the blood of patients
with psoriasis correlates with their disease severity.34 The
importance of specific effector ⁄memory T cells is now gener-
ally recognized in psoriasis,4 but it remains to be elucidated
why and where the effector T cells are activated. In this
regard, the innate immune response of the tonsils may play a
crucial role in the instigation and subsequent regulation of the
T-cell-mediated adaptive immune response. Thus, aberrant
tonsil responses to streptococcal infection could lead to altered
T-cell expansion and trafficking to the skin where they induce
an inflammatory response that initiates the psoriasis plaque.
This is further supported by the fact that similar oligoclonal T
cells have been isolated from tonsils and psoriatic plaques of
the same individual,35 with disease remission following tonsil-
lectomy.35
The potential of tonsillectomy for the
treatment of psoriasis
Almost a century ago, Winfield36 presented a series of six case
reports that first drew attention to the occurrence of psoriasis
following inflammation of the tonsils. b-Haemolytic strepto-
coccus was later identified as the infectious agent,20,23,37 lead-
ing to the onset of guttate psoriasis, or exacerbation of
chronic plaque psoriasis.
Streptococci are not fully eradicated with antibiotics such as
penicillin or erythromycin that do not penetrate host cells,38
as they are facultative intracellular bacteria39,40 unaffected by
conventional antibiotics. Rifampicin and clindamycin are also
active intracellularly38 and eliminate both extra- and intra-
cellular streptococci;41–44 however, even treatment with anti-
biotics is likely to have only a temporary benefit, as about
20% of healthy, asymptomatic individuals carry b-haemolytic
streptococci in their throat,24 making it likely that the bacte-
rium recolonizes the throat of the patients after cessation of
treatment. With respect to the treatment of psoriasis with anti-
biotics, there is a lack of adequately controlled clinical trials
(see Owen et al.45).
A search of the PubMed database using the search terms
‘psoriasis’, ‘tonsils’ and ‘tonsillectomy’ revealed 71 articles
from 1960 to 2012. After limiting our search to those studies
on ‘chronic plaque psoriasis’ or ‘guttate psoriasis’ or ‘psoriasis
vulgaris’, excluding ‘palmoplantar pustulosis’ or ‘pustulosis
palmaris et plantaris’, and following up citations within these
publications, we noted that there exist 12 original case reports
or studies on the effect of tonsillectomy on psoriasis
(Table 1). In the first report, Whyte and Baughman46
described the improvement of psoriasis and decrease in anti-
streptolysin O titres following tonsillectomy of three patients
with guttate psoriasis. This was followed by the first con-
trolled trial, a 1967 report from Germany47 that described 92
patients with psoriasis with chronic tonsillitis, of whom 56
underwent tonsillectomy whereupon 34 (61%) improved and
22 (39%) appeared unchanged. This compares with the con-
trol group of 36 patients with psoriasis who did not have a
tonsillectomy, of whom 8 (22%) improved and 28 (78%)
were unchanged. The authors did not give details of whether
the control group was matched for age and sex, nor did they
use a quantitative scoring system for disease severity.
Later, Nyfors et al.48 conducted an uncontrolled retrospect-
ive study, which examined the effect of tonsillectomy on 74
young (mean age 14Æ2 years) patients with psoriasis vulgaris
that proved to be refractory to topical treatments. During the
follow-up period (mean 4Æ5 years), 32% of patients remained
clear of psoriasis, 39% had a considerable improvement, 22%
were unchanged and 7% worsened. Another case report49
describes the effect of tonsillectomy on two young sisters with
guttate psoriasis that developed 1 week after catching a cold
and severe sore throat. Interestingly, both sisters carried the
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human leucocyte antigen-B37 allele, which is part of one of
the psoriasis risk haplotypes.50 In both cases the skin lesions
cleared almost completely within 2 months of tonsillectomy;
however, the treatment was complicated by the postoperative
use of antibiotics and topical corticosteroid cream.
Over 10 years later, Hone et al.51 reported an uncontrolled
prospective study on 13 patients (mean age 17 years) with
recalcitrant psoriasis. The group consisted of six patients with
guttate psoriasis and seven with chronic plaque psoriasis.
From the group as a whole, seven patients showed complete
clearance and three showed significantly improved psoriasis
following tonsillectomy, with noticeable improvement within
a month. The data for the patients with guttate psoriasis was
more impressive, as the disease cleared in five out of six
patients, with the remaining patient having a significant
improvement. The authors claim that the patients served as
their own controls, yet they omitted to acknowledge that
patients with guttate psoriasis might have spontaneous remis-
sions. In the same year, a Japanese study including 35 patients
with psoriasis vulgaris52 reported that 49% of the patients
showed a clear improvement in their clinical symptoms fol-
lowing tonsillectomy, which was more effective for women
(84% having some degree of improvement) than men (31%).
It was also more effective in younger patients: 83% of those
under the age of 20 years showed some degree of improve-
ment, which fell to 68% in the under-30s category.
In 1998, Rosenberg et al.53 reported clearance of psoriasis
in nine of 14 patients following tonsillectomy, and a signifi-
cant improvement in the remaining five. All 14 patients had
evidence of streptococcal colonization that could not be
resolved by antibiotics. A year later, McMillin et al.54 gave
details of two case reports. The first was a 5-year-old girl








Whyte and Baughman46 U.S.A., 1964 3 Guttate psoriasis 15–23 (20) ‘Occasional plaques’ after
tonsillectomy
1 year
Cepicka and Tielsch47 Germany, 1967 92 Psoriasis associated
with infection
NR Symptom free in 61% after
tonsillectomy, vs. 8% in
nontonsillectomized group
2–5 years
Nyfors et al.48 Denmark, 1976 74 Psoriasis vulgaris 4–33 (14Æ2) All lesions cleared in 32%,
‘considerable improvement’





Saita et al.49 Japan, 1979 2 Guttate psoriasis 7, 11 Both ‘cleared almost
completely’ within 2 months
of tonsillectomy
NR
Hone et al.51 Ireland, 1996 13 6 Guttate psoriasis
7 Chronic plaque
psoriasis
6–28 (17) Guttate: 5 ⁄6 cleared, 1 ⁄6
improved
Plaque: 2 ⁄7 cleared, 2 ⁄7
improved, 3 ⁄7 unchanged
6–52 (26)
months





Rosenberg et al.53 U.S.A., 1998 14 NR NR All lesions cleared in 9 ⁄14
cases, improvement in 5 ⁄14
NR




All lesions cleared 16 months
Ozawa et al.55 Japan, 1999 385 Generalized pustular
psoriasis
NR ‘Effective’ in 16Æ7% of cases NR
Takahara et al.56 Japan, 2001 7 Psoriasis (?) 9–46 (23) All lesions cleared in 3 ⁄7,
80% of lesions cleared in
2 ⁄7, no change in 2 ⁄7
2–9 years
Diluvio et al.35 Germany, 2006 3 Recalcitrant nonpustular
chronic plaque psoriasis
with guttate flares
21, 29, 33 Complete remission (Psoriasis
Area and Severity
Index score = 0)
> 3 years
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who had severe early-onset psoriasis, a history of enlarged
tonsils and one episode of streptococcal pharyngitis. The sec-
ond was an 11-year-old boy with early-onset guttate psoriasis
and recurrent streptococcal pharyngitis. As with the earlier
report from Hone et al.,51 the children showed a marked
improvement in their psoriasis as early as 1 month after ade-
notonsillectomy and both were clear of psoriasis at a 16-
month follow-up examination. In the same year, Ozawa
et al.55 conducted a multicentre retrospective study based on
physician questionnaires, which included 385 cases of gener-
alized pustular psoriasis. They reported that tonsillectomy was
‘effective’ for 16Æ7% of the patients. A more recent report
came from Japan in 2001, where seven patients with psoria-
sis underwent tonsillectomy and were followed up for
2–9 years after surgery.56 All lesions had cleared in three
patients and 80% of lesions cleared in two patients, with no
changes in the disease of the remaining two. Of the five
patients showing improvement, four had a history of tonsilli-
tis making their skin lesions worse. The group of Prinz
followed three patients with recalcitrant chronic plaque psori-
asis with guttate flares for 3 years after tonsillectomy and
reported complete remission.35 Moreover, analysis of T-cell
receptor beta-chain variable region gene rearrangements
suggested that T cells from the same T-cell clones were
simultaneously present within the skin and tonsils of these
patients.35
These data are compelling but case reports carry limitations
inherent in their study design (or lack thereof), given that the
patients are managed in a noncontrolled environment, the
observation is based on an individual or small group, which
may not reflect a larger population, and some of the effects
noted may have simply arisen from the natural history of
the disease, rather than the treatment. Thus, we recently
completed a prospective, controlled, observer-blinded trial29
involving 29 patients with chronic psoriasis and a history of
exacerbation after sore throat, who were randomly assigned
to tonsillectomy (n = 15) or control (n = 14) groups and
were followed for 2 years. Of this group, 13 patients (86%)
showed sustained improvement after tonsillectomy ranging
from 30% to 90% reduction in disease severity. In addition to
clinical follow-up, we assessed blood T cell responses to pools
of short peptides derived from human epidermal keratins and
streptococcal M proteins, and found a close correlation
between the degree of clinical improvement in individual
patients and reduction in the frequency of peptide-reactive
skin-homing T cells in the blood.29 No corresponding clinical
or immunological changes were observed among the control
group.
Outlook
All of the studies and case reports reviewed here conclude that
tonsillectomy may be of considerable benefit to selected
patients. Psoriasis is influenced by multiple genetic polymor-
phisms and environmental factors,57 resulting in a range of
disease severity and course among patients, which is likely
reflected in the response to treatment.58,59 Some patients with
recalcitrant guttate or chronic plaque psoriasis, particularly those
with early-onset psoriasis that is exacerbated by streptococcal
tonsillitis, appear to have long-term remissions following tonsil-
lectomy. In our recent study,29 tonsillectomized patients not
only benefited in terms of reduction of skin lesions but they also
required less symptomatic treatment than the control patients,
indicating that longer-term follow-up studies should also focus
on that issue. Thus, in some cases, tonsillectomy could become
an adjunct to existing therapy, to reduce the dosage of drugs or
allow the use of a less potent drug to control the disease. This
becomes an interesting consideration in our era of expensive
biological treatments. However, it remains to be seen how
effective tonsillectomy is in the long term and exactly which
patent groups will gain the most benefit.
What’s already known about this topic?
• There is a well-established association between strepto-
coccal tonsillitis and psoriasis, yet studies on the efficacy
of tonsillectomy for psoriasis have never been afforded
mainstream attention.
What does this study add?
• We have reviewed tonsil immunology and how tonsil
infection could lead to skin disease.
• We have also reviewed all available reports of the out-
come of tonsillectomy on psoriasis, including a recent
observer-blinded prospective study, and identified
patients who may potentially benefit from this procedure.
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